FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations

Novo Nordisk Launches Mini Needle for Diabetics

Jan. 21, 2014

Novo Nordisk has launched its NovoFine Plus in Canada, the first of several countries slated to get the “ultra-thin, ultra-short” universal pen needle for patients with diabetes in 2014 and 2015.

The breadth of two human hairs and just 4 mm long, NovoFine Plus is Novo Nordisk’s shortest needle and designed to lessen pain and the risk of intramuscular injection, the Danish drugmaker said Monday.

“We know needle anxiety can be a real barrier when people with diabetes start insulin therapy, and in some people this fear really compromises their treatment,” said Jesper Kløve, senior vice president for device R&D at Novo Nordisk. The new needle uses SuperFlow technology, providing quicker injections with less force, the company said.

Unlike longer needles, NovoFine Plus can penetrate the skin at a 90 degree angle and inject without the need for a skin fold. It is compatible with all major diabetic pens, according to the company. — Meg Bryant

Subscribe to Devices & Diagnostics Letter for complete coverage of the medical devices industry. Click here for more information.